drugset / Trial / NCT01425463

A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized Trial to Evaluate Efficacy & Safety in Anemia Subjects

NCT01425463

Phase 3 Completed 256 enrolled Sanol GmbH
RandomizedParallel-groupTriple-blindTreatment

Summary

To evaluate the efficacy and safety of 12 weeks treatment with Ferrous (II) Glycine Sulphate Complex in comparison to Polyferose capsules in Chinese subjects with manifest Iron Deficiency Anemia.

Timeline

Start
2011-03
Primary completion
2013-10
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ferrous Sulfate Diagnostic / imaging agent 150 mg Oral
Subject ferrous(II)-glycine-sulphate complex Unknown 567.7 mg Oral